BO-653

DB19216InvestigationalSmall molecule

BO-653 is under investigation in clinical trial NCT00055510 (A Blinded Study Conducted at Multiple Centers Evaluating Various Doses of an Investigational Agent (BO-653) Against Placebo, for Safety and Effectiveness in...

Formula / weight: C₂₆H₄₄O₂ · 388.636 g/mol (avg)
Also known as: 4,6-bis(1,1-dimethylethyl)-2,3-dihydro-2,2-dipentyl-5-benzofuranol
Code names: BO-653

Resolves to

Compound

UNII2VSP9T5LRXCAS157360-23-1ChEMBLCHEMBL104186

Structure

InChIKeyAGURKSYKTJQPNA-UHFFFAOYSA-NSMILESCCCCCC1(CCCCC)CC2=C(O1)C=C(C(O)=C2C(C)(C)C)C(C)(C)C

What you can answer from here — as of July 10, 2024

1Clinical trialPhase, status and sponsor resolved per trial

Which companies are running trials of BO-653, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account